In this issue:
Meta-analysis of vasectomy and prostate cancer
Germline BRCA2 variants and platinum-based chemotherapy
Impact of subsequent metastases on costs and medical resource use
Overall survival surrogate measures
ProPSA as predictive marker for prostate cancer aggressiveness
Alcohol intake and risk of aggressive prostate cancer
177Lu-anti-PSMA in mCRPC
Risk-stratification based on MRI and PSA density
Partial prostatectomy for anterior prostate cancer
Radical treatment for disseminated prostate cancer
Please login below to download this issue (PDF)